PRESS RELEASE published on 01/23/2025 at 06:45, 1 year 1 month ago Galenica enregistre une nouvelle fois une forte croissance du chiffre d’affaires Galenica enregistre une nouvelle fois une forte croissance du chiffre d’affaires avec une évolution de 4,7% en 2024, dépassant ainsi le marché pharmaceutique suisse Chiffre D'affaires Croissance Perspectives Galenica Pharmaceutique
PRESS RELEASE published on 01/23/2025 at 06:45, 1 year 1 month ago Galenica reports strong sales growth once again Galenica reports strong sales growth once again in 2024, outperforming pharmaceutical market. Guidance for 2024 annual results confirmed, projecting EBIT growth between 8%-11% Sales Growth EBIT Growth Galenica Pharmaceutical Market 2024 Results
BRIEF published on 10/24/2024 at 06:50, 1 year 4 months ago Galenica Reports Robust Sales Growth in Third Quarter Sales Growth Pharmaceutical Market Galenica AG Generics And Biosimilars Logistics & IT
BRIEF published on 10/24/2024 at 06:50, 1 year 4 months ago Galenica annonce une forte croissance de son chiffre d'affaires au troisième trimestre Croissance Des Ventes Marché Pharmaceutique Galenica SA Génériques Et Biosimilaires Logistique Et Informatique
PRESS RELEASE published on 10/24/2024 at 06:45, 1 year 4 months ago Galenica increases sales growth in the third quarter Galenica reports 4.1% sales growth in the third quarter of 2024, outperforming the pharmaceutical market. Confirms sales growth outlook for 2024 2024 Outlook Sales Growth Galenica Pharmaceutical Market Third Quarter
PRESS RELEASE published on 10/24/2024 at 06:45, 1 year 4 months ago Galenica augmente la croissance du chiffre d’affaires au troisième trimestre Galenica a augmenté son chiffre d'affaires de 4.1% au troisième trimestre 2024, dépassant la croissance du marché pharmaceutique suisse. Perspectives 2024 confirmées avec une croissance du CA entre 3% et 5% Chiffre D'affaires Croissance Galenica Pharmaceutique Trimestriel
BRIEF published on 08/06/2024 at 07:05, 1 year 7 months ago Élargissement de la Direction et passage de témoin au poste de CFO chez Galenica Stratégie CFO Reorganisation Galenica Pharmacies
BRIEF published on 08/06/2024 at 07:05, 1 year 7 months ago Expansion of management and handover to the position of CFO at Galenica CFO Reorganization Strategy Galenica Pharmacies
PRESS RELEASE published on 08/06/2024 at 07:00, 1 year 7 months ago Élargissement de la Direction et passage de témoin au poste de CFO Galenica AG réoriente ses pharmacies vers une approche client; Stephan Mignot rejoint la Direction pour le marketing. Fusion de 'Products & Brands' et 'Home Care'. Changement de CFO. Croissance stratégique CFO Marketing Croissance Stratégique Galenica AG Pharmacies
PRESS RELEASE published on 08/06/2024 at 07:00, 1 year 7 months ago Expansion of the Executive Committee and handover of the position of CFO Galenica restructures its executive team to enhance customer focus. CFO Felix Burkhard to step down by end of 2024, Julian Fiessinger to take over. Strategic aims include growth and improved customer satisfaction CFO Restructuring Growth Galenica Customer Focus
Published on 03/20/2026 at 13:30, 2 days 6 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 7 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/22/2026 at 12:23, 7 hours 43 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 21 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 23 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 23 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 19:00, 2 days 1 hour ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 1 hour ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 1 hour ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 1 hour ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
